May 2021 Simoa® Publications: Alzheimer’s Disease and Multiple Sclerosis
Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer’s disease
Alawode DOT, et al.
J Intern Med. 2021 May 22.
Alzheimer’s Disease
Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-analysis
Bellaver B, et al.
Neurology. 2021
Alzheimer’s Disease
Development of immunoprecipitation – two-dimensional liquid chromatography – mass spectrometry methodology as biomarker read-out to quantify phosphorylated tau in cerebrospinal fluid from Alzheimer disease patients
Bijttebier S, et al.
Journal of Chromatography A. 2021:462299
Alzheimer’s Disease
NFL strongly correlates with TNF-R1 in the plasma of AD patients, but not with cognitive decline
Delaby C, et al.
Sci Rep. 2021;11:10283
Alzheimer’s Disease
Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population
Gleerup HS, et al.
Front Aging Neurosci. 2021;13
Alzheimer’s Disease
Water exchange rate across the blood-brain barrier is associated with CSF amyloid-β 42 in healthy older adults
Gold BT, et al.
Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association. 2021
Alzheimer’s Disease
Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
Guo Y, et al.
Alzheimers Res Ther. 2021;13:93
Alzheimer’s Disease
Blood-brain barrier breakdown in relationship to Alzheimer and vascular disease
Lin BSZ, et al.
Ann Neurol. 2021 May 26
Alzheimer’s Disease
Biomarkers and Their Implications in Alzheimer’s Disease: A Literature Review
Marcucci V and Kleiman J
Exploratory Research and Hypothesis in Medicine. 2021
Alzheimer’s Disease
Serum neurofilament levels reflect outer retinal layer changes in multiple sclerosis
Seitz CB, et al.
Therapeutic Advances in Neurological Disorders. 2021;14:17562864211003478
Multiple Sclerosis
Highly specific and ultrasensitive plasma test detects Abeta(1-42) and Abeta(1-40) in Alzheimer’s disease
Thijssen EH, et al.
Sci Rep. 2021;11:9736
Alzheimer’s Disease
Low serum neurofilament light chain values identify optimal responders to dimethyl fumarate in multiple sclerosis treatment
Walo-Delgado PE, et al.
Sci Rep. 2021 Apr 29;11(1):9299
Multiple Sclerosis
Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer’s disease screening and staging
Jiang Y, et al.
Alzheimers Dement. 2021 May 25
Alzheimer’s Disease
A neurologist’s perspective on serum neurofilament light in the memory clinic: a prospective implementation study
Willemse EAJ, et al.
Alzheimers Res Ther. 2021 May 18;13(1):101
Alzheimer’s Disease
May 2021 Simoa® Publications in Other Therapeutic Areas
